1,25-Dihydroxy vitamin D3: Can it be an effective therapeutic option for aggressive fibromatosis

Medical Hypotheses

Volumn 64, Issue 2, 2005, Pages 333-336

  Yildiz, F ^a   Kars, A ^a   Cengiz, M ^a   Yildiz, O ^b   Akyurek S ^c   Selek, U ^a   Ozyigit, G ^a   Atahan, I L ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; TAMOXIFEN; TOREMIFENE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; DRUG MECHANISM; FIBROMATOSIS; HOMEOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ANTINEOPLASTIC AGENTS; CALCITRIOL; COLLAGEN; FIBROMA; HUMANS;

EID: 11144250941     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.07.020     Document Type: Article

References (46)

1. C.J. Shields, W.O. Winter, W.O. Kirwan, and H.P. Redmond Desmoid tumors EJSO 27 2001 701 706
2. J.J. Nuyttens, F.R. Rust, C.R. Thomas, and A.T. Turrisi Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors. A comparative review of 22 articles Cancer 88 2000 1517 1523
3. D.W. Easter, and N.A. Halasz Recent trends in the management of desmoid tumors: Summary of 19 cases and review of the literature Ann Surg 210 1989 765 769
4. M.T. Ballo, G.K. Zagars, and A. Pollack Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy J Clin Oncol 17 1999 158 167
5. A. Azzarelli, A. Gronchi, and R. Bertulli Low dose chemotherapy with Methotrexate and Vinblastine for patients with advanced aggressive fibromatosis Cancer 92 5 2001 1259 1264
6. S.H. Ocuno, and J.H. Edmonson Combination chemotherapy for desmoid tumors Cancer 97 2003 1134 1135
7. S.R. Patel, H.L. Evans, and R.S. Benjamin Combination chemotherapy in adult desmoid tumors Cancer 72 11 1993 3244 3247
8. J. Janinis, M. Patriki, and L. Vini The pharmacological treatment of aggressive fibromatosis: a systematic review Ann Oncol 14 2003 181 190
9. F. Tonelli, F. Ficari, R. Valanzxano, and M.L. Brandi Treatment of desmoids and mesenteric fibromatosis in familial adenomatosis poliposis with raloxifene Tumori 89 4 2003 391 396
10. M.D. Brooks, S.R. Ebbs, and A.A. Colletta Desmoid tumors treated with triphenylenes Eur J Cancer 28A 1992 1014 1018
11. W.R. Waddell, and W.M. Kirsch Testolactone, sulindac, warfarin and Vitamin K1 for unresectable desmoid tumors Am J Surg 161 1991 416 421
12. W.A. Klein, H.H. Miller, and M. Anderson The use of indomethacin, sulindac and tamoxifen for the treatment of desmoid tumors associated with familial poliposis Cancer 60 1987 2863 2868
13. K. Tsukada, J.M. Church, and D.J. Jagelman Noncytotoxic therapy for intraabdominal desmoid tumor in patients with familial adenomatosis poliposis Dis Colon Rectum 35 1992 29 33
14. A. Hansmann, C. Adolp, and T. Vogel High dose tamoxifen and sulindac as first line treatment for desmoid tumors Cancer 100 2004 612 620
15. M. Casado, M. Martin, A. Munoz, and J. Bernal vitamin D3 inhibits proliferation and increases c-myc expression in fibroblasts from psoriatic patients J Endocrinol Invest 21 8 1998 520 525
16. E. Abe, C. Miyaura, and H. Sakagami Differentiation of mouse myeloid leukemia cells induced by 1,25-dihydroxyvitamin D3 Proc Natl Acad Sci USA 76 1981 4990 4994
17. J. Akther, I. Lu, and M. Finlay 1α,25-dihydroxy vitamin D3 and its analogues, EB1089 and CB1093, profoundly inhibit the in vitro proliferation of the human hepatoblastoma cell line HEPG2 ANZ J Surg 71 2001 414 417
18. J. Akther, M. Goerdel, and D.L. Morris A vitamin D3 analogue (EB1089) inhibits in vitro cellular proliferation of human colon cancer cells Br J Surg 83 1996 229 230
19. S.Y. James, A.G. Mackay, and K.W. Colston Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells J Stereoid Biochem Mol Biol 58 1996 395 401
20. M.K. Polar, C. Gennings, and M. Park Effect of the vitamin D3 analog ILX 23-7553 on apoptosis and sensitivity to fractionated radiation in breast tumor cells and normal human fibroblasts Cancer Chemother Pharmacol 51 5 2003 415 421
21. H. Hyodo, A. Kimura, and Y. Nakata 1-alpha-Hydroxyvitamin D3 in the treatment of primary myelofibrosis: in vitro effect of vitamin D3 metabolytes on the bone marrow fibroblasts Int J Hematol 57 2 1993 131 137
22. T.M. Beer, and A. Myrthue Calcitriol in cancer treatment: from Lab to clinic Mol Cancer Ther 3 3 2004 373 381
23. N. Swamy, K.S. Persons, T.C. Chen, and R. Ray 1alpha,25-Dihydroxyvitamin D3-3beta-(2)-bromoacetate, an affinity labeling derivative of 1alpha,25-dihydroxyvitamin D3 displays strong antiproliferative and cytotoxic behavior in prostate cancer cells Cell Biochem 89 5 2003 909 916
24. S.R. Evans, A.M. Houghton, and L. Schumaker Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines J Surg Res 15 61 1996 127 133
25. H. Yabushita, M. Hirata, M. Noguchi, and M. Nakanishi Vitamin D receptor in endometrial carcinoma and the differentiation inducing effect of 1,25 dihydroxyvitamin D3 on endometrial carcinoma cell lines J Obstet Gyneecol Res 22 1996 529 539
26. B.R. Konety, J.P. Lavelle, and G. Pirtskalaisvili Effects of Vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo J Urol 165 2001 253 258
27. Y. Higashimato, M. Ohata, and K. Nishio 1α,25-dihydroxyvitamin D3 and all-trans-retinoic acid inhibit the growth of a lung cancer cell line Anticancer Res 16 1996 2653 2659
28. G. Zugmaier, R. Jager, and B. Grage Growth inhibitory effects of Vitamin D analogues and retinoids on human pancreatic cancer cells Br J Cancer 73 1996 1341 1346
29. G. Wu, R.S. Fan, and W. Li Modulation of cell cycle control by Vitamin D3 and its analogue, EB 1089 in human breast cancer cell lines Oncogene 15 13 1997 1555 1563
30. T. Kumagai, J. O'Kelly, J.W. Said, and P.H. Koeffler Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma and colon cancer cells J Natl Cancer Inst 95 2003 896 905
31. K. Koli, and J. Keski-Oja 1.25 dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and latent form binding protein in breast carcinoma cells Cancer Res 55 1995 1540 1546
32. H. Jiang, J. Lin, and Z.Z. Su Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53 Oncogene 9 1994 3397 3406
33. L.E. Harrison, Q.M. Wang, and G.P. Studzinski 1,25 dihydroxyvitamin D3 induced retardation of G2/M transverse is associated with decreased p34(cdc2) in HL60 cells J cell Biochem 75 1999 226 234
34. M. Guzey, S. Kitado, and J.C. Reed Apoptosis induction by 1α,25-dihydroxyvitamin D3 in prostate cancer Mol Cancer Ther 1 2002 667 677
35. C. Pepper, A. Thomas, and T. Hoy The vitamin D3 analog EB 11089 induces apoptosis via a p-53 independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B cell chronic lymphocytic leukemia cells in vitro Blood 101 2003 2454 2460
36. S.Y. James, A.G. Mackay, and K.W. Colston Effects of 1,25- dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells J Steroid Biochem Mol Biol 58 1996 395 401
37. S.P. Xie, S.Y. James, and K.W. Kolston Vitamin D derivates inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells J Endocrinol 154 1997 495 504
38. H.M. Hirri, and R.J. Gren Myelodysplasia and bone marrow fibrosis treated with calcitriol and venesection Leuk Lymphoma 43 7 2002 1489 1491
39. D.M. Mc Carthy, J.A. Hibbin, and J.M. Goldman A role for 1,25-dihydroxyvitamin D3 in control of bone marrow collagen deposition? Lancet 1 8368 1984 78 80
40. F. Yildiz, A. Kars, and M. Cengiz Possible therapeutic role of Vitamin D3 in Aggressive Fibromatosis Jpn J Clin Oncol 34 8 2004 1 4
41. M. Shabanang, A.E. Buffan, and J.M. Nolla The effect of 1,25-dihydroxyvitamin D3 on the growth of soft tissue sarcoma cells as mediated by the vitamin D receptor Ann Surg Oncol 3 2 1996 144 149
42. S. Sundaram, M. Chaudhry, and D. Reardon EB 1089 enhances the antiproliferative and apoptotic effects of adriamycin in MCF-7 breast tumor cells Breast Cancer Res Treat 63 2000 1 10
43. S. Sundaram, A. Sea, and S. Feldman The combination of a potent vitamin D3 analog, EB 1089, with ionizing radiation reduces tumor growth and induces apoptosis of MCF-7 breast tumor xenografts in nude mice Clin Cancer Res 9 2003 2350 2356
44. N. Dunlap, G.G. Schwartz, and D. Eads 1α,25-dihydroxyvitamin D3(calcitriol) and its analogue, 19-1,25-(OH)2D2, potentiate the effects of ionizing radiation in human prostate cancer cells Br J Cancer 89 2003 746 753
45. A. Ravid, D. Rocker, and A. Machlenkin 1,25-dihydroxyvitamin D3 enhances the suspectibility of breast cancer cells to doxorubicin induced oxidative damage Cancer 59 1999 862 867
46. E. Hall Radiosensitivity an cell age in the mitotic cycle E.J. Hall Radiobiology for the radiologist 5 ed. 2000 J.B. Lippincott Philedelphia 51 65